|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM279380097 |
003 |
DE-627 |
005 |
20231225022829.0 |
007 |
cr uuu---uuuuu |
008 |
231225s2018 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2017.12.005
|2 doi
|
028 |
5 |
2 |
|a pubmed24n0931.xml
|
035 |
|
|
|a (DE-627)NLM279380097
|
035 |
|
|
|a (NLM)29274388
|
035 |
|
|
|a (PII)S1521-6616(17)30656-3
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Rabani, Mariam
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a IL-21 dependent Granzyme B production of B-cells is decreased in patients with lupus nephritis
|
264 |
|
1 |
|c 2018
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 22.04.2019
|
500 |
|
|
|a Date Revised 22.04.2019
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Copyright © 2017 Elsevier Inc. All rights reserved.
|
520 |
|
|
|a OBJECTIVES: B-cells play a crucial role in the pathogenesis of lupus nephritis. Recently, a separate subset has been discovered characterized by expression of Granzyme B. The aim of this study is to investigate this subset in patients with systemic lupus erythematosus (SLE)
|
520 |
|
|
|a METHODS: Isolated PBMCs of SLE-patients (n=30) and healthy controls (n=21) were in vitro stimulated with CPG, IgG+IgM and IL-21. Patients were sub-grouped in patients with and without biopsy proven lupus nephritis. B-cells were analyzed for intracellular Granzyme B expression by flow cytometry
|
520 |
|
|
|a RESULTS: The strongest stimulus for Granzyme B secretion of B-cells was IgG+IgM in presence of IL-21. SLE-patients had a significant decreased percentage of Granzyme B+ B-cells in particular SLE-patients with active disease and with lupus nephritis
|
520 |
|
|
|a CONCLUSIONS: The frequency of GrB+ producing B-cells is reduced in SLE patients. This may contribute to an imbalanced B-cell regulation towards effector B-cells which might promote the development of lupus nephritis
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
4 |
|a Granzyme B
|
650 |
|
4 |
|a IL-21
|
650 |
|
4 |
|a Lupus nephritis
|
650 |
|
4 |
|a SLE
|
650 |
|
7 |
|a Antigens, CD19
|2 NLM
|
650 |
|
7 |
|a Immunoglobulin G
|2 NLM
|
650 |
|
7 |
|a Immunoglobulin M
|2 NLM
|
650 |
|
7 |
|a Interleukins
|2 NLM
|
650 |
|
7 |
|a Receptors, Interleukin-21
|2 NLM
|
650 |
|
7 |
|a Granzymes
|2 NLM
|
650 |
|
7 |
|a EC 3.4.21.-
|2 NLM
|
650 |
|
7 |
|a interleukin-21
|2 NLM
|
650 |
|
7 |
|a MKM3CA6LT1
|2 NLM
|
700 |
1 |
|
|a Wilde, Benjamin
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Hübbers, Katharina
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Xu, Shilei
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Kribben, Andreas
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Witzke, Oliver
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Dolff, Sebastian
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 188(2018) vom: 08. März, Seite 45-51
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:188
|g year:2018
|g day:08
|g month:03
|g pages:45-51
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2017.12.005
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 188
|j 2018
|b 08
|c 03
|h 45-51
|